Chen C, Li Y, Hu S, Zhou W, Meng Y, Li Z
Oncogene. 2018; 38(13):2364-2379.
PMID: 30518875
PMC: 6705423.
DOI: 10.1038/s41388-018-0584-6.
Qu J, Sun W, Zhong J, Lv H, Zhu M, Xu J
J Cell Biol. 2017; 216(2):409-424.
PMID: 28122957
PMC: 5294784.
DOI: 10.1083/jcb.201607008.
Oldemeyer S, Franz S, Wenzel S, Essen L, Mittag M, Kottke T
J Biol Chem. 2016; 291(27):14062-14071.
PMID: 27189948
PMC: 4933166.
DOI: 10.1074/jbc.M116.726976.
Kirschbaum M, Frankel P, Synold T, Xie Z, Yen Y, Popplewell L
Leuk Lymphoma. 2016; 57(10):2307-14.
PMID: 26895565
PMC: 4969190.
DOI: 10.3109/10428194.2016.1146947.
Taricani L, Shanahan F, Malinao M, Beaumont M, Parry D
PLoS One. 2014; 9(11):e111714.
PMID: 25375241
PMC: 4222937.
DOI: 10.1371/journal.pone.0111714.
The conserved Lys-95 charged residue cluster is critical for the homodimerization and enzyme activity of human ribonucleotide reductase small subunit M2.
Chen X, Xu Z, Zhang L, Liu H, Liu X, Lou M
J Biol Chem. 2013; 289(2):909-20.
PMID: 24253041
PMC: 3887214.
DOI: 10.1074/jbc.M113.524546.
Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy.
Wang L, Meng L, Wang X, Ma G, Chen J
Tumour Biol. 2013; 35(3):1899-906.
PMID: 24155212
DOI: 10.1007/s13277-013-1255-4.
A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study.
Chao J, Synold T, Morgan Jr R, Kunos C, Longmate J, Lenz H
Cancer Chemother Pharmacol. 2011; 69(3):835-43.
PMID: 22105720
PMC: 3288125.
DOI: 10.1007/s00280-011-1779-5.
A hot oxidant, 3-NO2Y122 radical, unmasks conformational gating in ribonucleotide reductase.
Yokoyama K, Uhlin U, Stubbe J
J Am Chem Soc. 2010; 132(43):15368-79.
PMID: 20929229
PMC: 3005585.
DOI: 10.1021/ja1069344.
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.
Shibata S, Doroshow J, Frankel P, Synold T, Yen Y, Gandara D
Cancer Chemother Pharmacol. 2009; 64(6):1149-55.
PMID: 19322566
PMC: 3046108.
DOI: 10.1007/s00280-009-0977-x.
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.
Kolesar J, Huang W, Eickhoff J, Hahn K, Alberti D, Attia S
Cancer Chemother Pharmacol. 2008; 64(1):79-86.
PMID: 18941749
PMC: 3043989.
DOI: 10.1007/s00280-008-0845-0.
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.
Souglakos J, Boukovinas I, Taron M, Mendez P, Mavroudis D, Tripaki M
Br J Cancer. 2008; 98(10):1710-5.
PMID: 18414411
PMC: 2391126.
DOI: 10.1038/sj.bjc.6604344.
Neuroprotective activity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (PAN-811), a cancer therapeutic agent.
Jiang Z, Lebowitz M, Ghanbari H
CNS Drug Rev. 2006; 12(1):77-90.
PMID: 16834759
PMC: 6741723.
DOI: 10.1111/j.1527-3458.2006.00077.x.
Identification of ribonucleotide reductase protein R1 as an activator of microtubule nucleation in Xenopus egg mitotic extracts.
Takada S, Shibata T, Hiraoka Y, Masuda H
Mol Biol Cell. 2000; 11(12):4173-87.
PMID: 11102516
PMC: 15065.
DOI: 10.1091/mbc.11.12.4173.
Yeast ribonucleotide reductase has a heterodimeric iron-radical-containing subunit.
Chabes A, Domkin V, Larsson G, Liu A, Graslund A, Wijmenga S
Proc Natl Acad Sci U S A. 2000; 97(6):2474-9.
PMID: 10716984
PMC: 15953.
DOI: 10.1073/pnas.97.6.2474.
Molecular characterization of tobacco ribonucleotide reductase RNR1 and RNR2 cDNAs and cell cycle-regulated expression in synchronized plant cells.
Chaboute M, Combettes B, Clement B, Gigot C, Philipps G
Plant Mol Biol. 1998; 38(5):797-806.
PMID: 9862497
DOI: 10.1023/a:1006083318906.
Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential.
Zhou B, Tsai P, Ker R, Tsai J, Ho R, Yu J
Clin Exp Metastasis. 1998; 16(1):43-9.
PMID: 9502076
DOI: 10.1023/a:1006559901771.
Mapping of the ribonucleotide reductase genes (Rrm1, Rrm2) in the rat.
Klinga-Levan K, Helou K, Issa R, Szpirer C, Szpirer J, Levan G
Mamm Genome. 1997; 8(1):47-9.
PMID: 9021149
DOI: 10.1007/s003359900346.
Identification and isolation of the gene encoding the small subunit of ribonucleotide reductase from Saccharomyces cerevisiae: DNA damage-inducible gene required for mitotic viability.
Elledge S, Davis R
Mol Cell Biol. 1987; 7(8):2783-93.
PMID: 3313004
PMC: 367895.
DOI: 10.1128/mcb.7.8.2783-2793.1987.
Immunocytochemical evidence for the cytoplasmic localization and differential expression during the cell cycle of the M1 and M2 subunits of mammalian ribonucleotide reductase.
Engstrom Y, Rozell B
EMBO J. 1988; 7(6):1615-20.
PMID: 3049070
PMC: 457144.
DOI: 10.1002/j.1460-2075.1988.tb02987.x.